Blue Door Pharma is able to exclusively provide NmVac-4, a low-cost, high quality meningococcal meningitis tetravalent polysaccharide vaccine to the Middle East, Asia and other global customers through our sales and distribution rights. The NmVac-4 vaccine is manufactured with zero animal-based derivatives.

In addition, we have access to tens of thousands of US-made medications, both name brand and generic, to contribute to the global health needs of millions of people.

Leave a Reply

Your email address will not be published. Required fields are marked *